Target intelligence / Profile preview

General transcription factor IIi pseudogene 1 (GTF2IP1)

Target
GTF2IP1
Molecular classification
Other (processed pseudogene)
01

Overview

General transcription factor IIi pseudogene 1 (GTF2IP1) is a pseudogene located near the commonly deleted region in Williams-Beuren syndrome on chromosome 7q11.23. Unlike GTF2I, which is a functional protein-coding gene encoding the transcription factor TFII-I, GTF2IP1 is a partially truncated, expressed pseudogene that does not produce a functional protein product and is not implicated as a therapeutic target. Its main relevance is as a genomic marker near chromosomal rearrangement breakpoints, potentially predisposing to unequal recombination in Williams-Beuren syndrome, but it does not have known molecular, biological, or disease roles nor interactions with drugs[3]. GTF2IP1 is a pseudogene, not a functional gene or actionable therapeutic target. Pseudogenes do not produce active proteins[3]. The functional paralog/related gene in this locus is GTF2I (General transcription factor IIi), a multifunctional transcription factor involved in transcriptional regulation, with disease roles in Williams-Beuren syndrome and potentially other conditions[2][4]. References in the literature to regulatory or disease functions concern GTF2I or GTF2IRD1, not GTF2IP1 itself[1][2][5]. If you are looking for the functional molecule in this region, the canonical entry should be: GTF2I (General transcription factor IIi) — not GTF2IP1. If you intended to inquire about the pseudogene as a putative target, it is not considered a valid biological target for therapeutic intervention or research in a classic sense[3][7].

Other names
WBSCR7Williams-Beuren syndrome chromosome region 7

Beyond the preview

Go deeper on General transcription factor IIi pseudogene 1 (GTF2IP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor IIi pseudogene 1 (GTF2IP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call